12:50 Jan 20

Bafna Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
117.20
-4.35 (-3.58%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bafna Pharmaceuticals Ltd. Financials

Bafna Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
117.20
-4.35 (-3.58%)
12:50 Jan 20
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

56/100
Affordable Valuation

Technical

49/100
Technically Neutral

Strength

5

Weakness

9

Opportunity

0

Threats

0

-99.01 %

ROE %

-34.67 %

ROA %

3.71

EPS

-17.59

BVPS

-58.22 %

Net Profit Margin

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales
85.32 64.96 47.17 43.36 42.47
Operating Expenses +
84.8 70.77 82.31 56.7 41.24
Raw Material
66.73 55.01 34.19 26.99 23.22
Increase Decrease in Cost
-0.65 -3.09 4.09 0.81 -3.24
Other Manufacturing Expense
6.84 5.86 5.61 6.76 7.04
Employee Cost
6.99 6.81 7.47 9.01 10.25
Miscellaneous Expenses
106.67 86.58 56.93 14.05 4.01
Operating Profit
0.52 -5.81 -35.14 -13.34 1.23
Other Income
1.98 1.14 31.33 0.65 0.26
Depreciation
4.86 4.22 3.97 3.48 3.27
Interest
12.96 11.47 6.94 2.13 0.1
Profit before tax and exceptio..
-15.32 -20.36 -14.72 -18.29 -1.88
Exceptional Items
0 0 0 1.01 -22.56
PBT
-15.32 -20.36 -14.72 -17.28 -24.44
Provision for Taxation
-0.18 -0.9 2.19 1.07 0
Net Profit
-15.14 -19.46 -16.91 -18.35 -24.44
NET Profit after MI
-14.03 -19.09 -16.74 -18.87 -24.73
EPS
-8.8 -10.43 -7.15 -11.48 -15.52
Operating Profit Margin (%)
0.61 -8.94 -74.5 -30.77 2.9
Net Profit Margin (%)
-16.44 -29.39 -35.49 -43.52 -58.23

Bafna Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 75.00 75.00 75.00 75.00 88.30 88.30
FII 9.30 9.30 9.30 8.50 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 15.70 15.70 15.70 16.50 11.70 11.70
Shareholder Shares Holding %
Download Our App On: